Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Microhomology-mediated end joining drives complex rearrangements and over expression of MYC and PVT1 in multiple myeloma.

Mikulasova A, Ashby C, Tytarenko RG, Qu P, Rosenthal A, Dent JA, Ryan KR, Bauer MA, Wardell CP, Hoering A, Mavrommatis K, Trotter M, Deshpande S, Yaccoby S, Tian E, Keats J, Auclair D, Jackson GH, Davies FE, Thakurta A, Morgan GJ, Walker BA.

Haematologica. 2019 Jun 20. pii: haematol.2019.217927. doi: 10.3324/haematol.2019.217927. [Epub ahead of print]

2.

Phospholipase A2 activity during the replication cycle of the flavivirus West Nile virus.

Liebscher S, Ambrose RL, Aktepe TE, Mikulasova A, Prier JE, Gillespie LK, Lopez-Denman AJ, Rupasinghe TWT, Tull D, McConville MJ, Mackenzie JM.

PLoS Pathog. 2018 Apr 30;14(4):e1007029. doi: 10.1371/journal.ppat.1007029. eCollection 2018 Apr.

3.

The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.

Mikulasova A, Wardell CP, Murison A, Boyle EM, Jackson GH, Smetana J, Kufova Z, Pour L, Sandecka V, Almasi M, Vsianska P, Gregora E, Kuglik P, Hajek R, Davies FE, Morgan GJ, Walker BA.

Haematologica. 2017 Sep;102(9):1617-1625. doi: 10.3324/haematol.2017.163766. Epub 2017 May 26.

4.

A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.

Sandecká V, Hájek R, Pour L, Špička I, Ščudla V, Gregora E, Radocha J, Walterová L, Kessler P, Zahradová L, Adamová D, Valentova K, Vonke I, Obernauerová J, Starostka D, Wróbel M, Brožová L, Jarkovský J, Mikulášová A, Říhová L, Ševčíková S, Straub J, Minařík J, Adam Z, Krejčí M, Král Z, Maisnar V; Czech Myeloma Group.

Eur J Haematol. 2017 Jul;99(1):80-90. doi: 10.1111/ejh.12894. Epub 2017 May 11.

PMID:
28384387
5.

Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM).

Wayhelova M, Mikulasova A, Smetana J, Vallova V, Blazkova D, Filkova H, Moukova L, Kuglik P.

Neoplasma. 2016;63(5):779-88. doi: 10.4149/neo_2016_516.

PMID:
27468883
6.

Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.

Mikulasova A, Smetana J, Wayhelova M, Janyskova H, Sandecka V, Kufova Z, Almasi M, Jarkovsky J, Gregora E, Kessler P, Wrobel M, Walker BA, Wardell CP, Morgan GJ, Hajek R, Kuglik P.

Eur J Haematol. 2016 Dec;97(6):568-575. doi: 10.1111/ejh.12774. Epub 2016 Jun 9.

PMID:
27157252
7.

[Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].

Šoukalová J, Vejmělková K, Cermanová T, Kašíková K, Mikulášová A, Janyšková H, Melichárková K, Pavelka Z, Ježová M, Pospíšilová Š, Kuglík P, Valášková I, Gaillyová R, Štěrba J, Zitterbart K.

Klin Onkol. 2016;29 Suppl 1:S83-8. Czech.

PMID:
26691947
8.

[First experiences with preimplantation genetic screening of chromosomal aberrations using oligonucleotide-based array comparative genomic hybridization].

Kuglík P, Smetana J, Němcová D, Vallová V, Mikulášová A, Gaillyová R, Hubinka V, Koudelka M.

Cas Lek Cesk. 2015;154(3):127-31. Czech.

PMID:
26311028
9.

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.

Walker BA, Boyle EM, Wardell CP, Murison A, Begum DB, Dahir NM, Proszek PZ, Johnson DC, Kaiser MF, Melchor L, Aronson LI, Scales M, Pawlyn C, Mirabella F, Jones JR, Brioli A, Mikulasova A, Cairns DA, Gregory WM, Quartilho A, Drayson MT, Russell N, Cook G, Jackson GH, Leleu X, Davies FE, Morgan GJ.

J Clin Oncol. 2015 Nov 20;33(33):3911-20. doi: 10.1200/JCO.2014.59.1503. Epub 2015 Aug 17.

10.

Analysis of B-cell subpopulations in monoclonal gammopathies.

Všianská P, Říhová L, Varmužová T, Suská R, Kryukov F, Mikulášová A, Kupská R, Penka M, Pour L, Adam Z, Hájek R.

Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):e61-71. doi: 10.1016/j.clml.2014.12.003. Epub 2014 Dec 12.

PMID:
25578543
11.

Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.

Smetana J, Frohlich J, Zaoralova R, Vallova V, Greslikova H, Kupska R, Nemec P, Mikulasova A, Almasi M, Pour L, Adam Z, Sandecka V, Zahradová L, Hajek R, Kuglik P.

Biomed Res Int. 2014;2014:209670. doi: 10.1155/2014/209670. Epub 2014 Jun 2.

12.

Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH.

Smetana J, Dementyeva E, Kryukov F, Nemec P, Greslikova H, Kupska R, Mikulasova A, Ihnatova I, Hajek R, Kuglik P.

Neoplasma. 2014;61(1):48-55.

PMID:
24195508
13.

Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.

Smetana J, Berankova K, Zaoralova R, Nemec P, Greslikova H, Kupska R, Mikulasova A, Frohlich J, Sevcikova S, Zahradova L, Krejci M, Sandecka V, Almasi M, Kaisarova P, Melicharova H, Adam Z, Penka M, Jarkovsky J, Jurczyszyn A, Hajek R, Kuglik P.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):123-30. doi: 10.1016/j.clml.2012.11.012. Epub 2013 Jan 4.

PMID:
23291040
14.

Oligonucleotide-based array CGH as a diagnostic tool in multiple myeloma patients.

Smetana J, Fröhlich J, Vranová V, Mikulásová A, Kuglik P, Hájek R.

Klin Onkol. 2011;24 Suppl:S43-8.

PMID:
21923064
15.

Efficient RNA polyuridylation by noncanonical poly(A) polymerases.

Rissland OS, Mikulasova A, Norbury CJ.

Mol Cell Biol. 2007 May;27(10):3612-24. Epub 2007 Mar 12.

16.

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, García-Sastre A.

J Virol. 2003 Jul;77(14):7945-56.

17.

Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.

Tumpey TM, García-Sastre A, Mikulasova A, Taubenberger JK, Swayne DE, Palese P, Basler CF.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13849-54. Epub 2002 Oct 4.

18.

Messenger RNAs that are not synthesized by RNA polymerase II can be 3' end cleaved and polyadenylated.

Fodor E, Mikulasova A, Mingay LJ, Poon LL, Brownlee GG.

EMBO Rep. 2000 Dec;1(6):513-8.

19.

Transcription and replication of the influenza a virus genome.

Mikulásová A, Varecková E, Fodor E.

Acta Virol. 2000 Oct;44(5):273-82. Review.

PMID:
11252672

Supplemental Content

Loading ...
Support Center